B2B verification
Buyer eligibility policy
Helix BioPure is designed for verified business, institutional, and laboratory research accounts only. Consumer, patient, personal-use, and veterinary-use ordering is not supported.
Draft policy scaffold. This page must be reviewed by qualified legal/compliance counsel before commercial launch.
Eligible account types
- Verified laboratories and research organizations.
- Universities and academic research departments.
- Biotech, pharmaceutical, diagnostic, analytical-service, or life-science research companies.
- Contract research organizations and qualified institutional procurement teams.
- Credentialed researchers ordering on behalf of an approved organization.
Verification may include
- Organization name, role, business/institutional affiliation, authorized shipping address, and research-use purpose.
- Research-use-only attestation and prohibited-use acknowledgement.
- Shipping destination review, account-risk review, and manual escalation when needed.
- Additional documentation when an order, destination, payment behavior, or support request requires manual compliance review.
- Ongoing order-level review after account approval.
Ineligible or escalated signals
- Consumer, patient, personal-use, bodybuilding, wellness, anti-aging, cosmetic, weight-loss, dietary-supplement, or veterinary-use intent.
- Requests for dosing, injection, reconstitution-for-administration, cycle/stack, protocol-for-self-use, medical, or veterinary guidance.
- Unverifiable organization identity, restricted destination, freight-forwarding/reshipping address, or support messages inconsistent with lawful laboratory research use.
Account denial or closure
Helix BioPure may deny, suspend, or close an account when a buyer fails verification, provides incomplete information, uses a personal-use signal, requests prohibited guidance, misrepresents intended use, attempts to order for a prohibited use, or creates unresolved compliance risk.
Account approval does not override product restrictions. Each order remains subject to review and refusal.